Driving while tired is just as risky as after drinking, experts warn

Nearly half of U.S. adults have driven while being so tired that it affected their ability to stay safe behind the wheel, a ...

Evaluating Inhibrx Biosciences (INBX) Valuation Following Breakthrough Phase 2 Results for Ozekibart

Inhibrx Biosciences (INBX) drew considerable attention after announcing that its lead candidate, ozekibart, delivered a clear progression-free survival benefit in advanced or metastatic chondrosarcoma ...